Internal Medicine, Nephrology · Bakersfield, CA
NPI
1275580367
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
5030 Office Park Dr
Bakersfield, CA, 93309
Phone (661) 323-2847
Groups this clinician bills Medicare through
Medicare paid, 2024
$562K
4,056 services
Medicare patients, 2024
784
Average age 68
Drug cost, 2024
$879K
3,201 prescriptions
Company payments, 2025
$704
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tariq Mubin was code 99232 (hospital e&m - subsequent), 1,031 times for 278 patients. In total Tariq Mubin billed 4,056 services in 18 codes, and Medicare paid $562K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,031 | 278 | $60.59 | $62K |
| 90960 ESRD Related Services (not dialysis) | Office | 858 | 245 | $276.21 | $237K |
| 99233 Hospital E&M - Subsequent | Facility | 523 | 163 | $91.42 | $48K |
| 99214 Office E&M - Established | Office | 494 | 196 | $96.39 | $48K |
| 90961 ESRD Related Services (not dialysis) | Office | 226 | 134 | $231.55 | $52K |
| 99222 Hospital E&M - Initial | Facility | 204 | 157 | $95.24 | $19K |
| 90962 ESRD Related Services (not dialysis) | Office | 173 | 84 | $157.38 | $27K |
| 99223 Hospital E&M - Initial | Facility | 139 | 121 | $126.01 | $18K |
| 90966 ESRD Related Services (not dialysis) | Office | 125 | 19 | $230.95 | $29K |
| 99213 Office E&M - Established | Office | 99 | 87 | $63.78 | $6,314 |
| 90935 Hemodialysis | Facility | 56 | 46 | $54.76 | $3,067 |
| 99204 Office E&M - New | Office | 41 | 41 | $134.87 | $5,530 |
| 99291 Critical Care E&M | Facility | 34 | 29 | $154.49 | $5,253 |
By year: 2022 $513K for 3,667 services; 2023 $567K for 3,828 services; 2024 $562K for 4,056 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tariq Mubin prescribed most often to Medicare patients was Calcium Acetate, with 250 prescriptions and refills. In total Tariq Mubin wrote 3,201 Medicare prescriptions that cost $879K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calcium Acetate Generic | 250 | 458 | 88 | $26K |
| Losartan Potassium Generic | 225 | 601 | 80 | $1,488 |
| Furosemide Generic | 196 | 446 | 70 | $2,000 |
| Amlodipine Besylate Generic | 158 | 362 | 54 | $791 |
| Sevelamer Carbonate Generic | 154 | 256 | 48 | $68K |
| Velphoro Sucroferric Oxyhydroxide | 124 | 140 | 36 | $355K |
| Nifedipine Er Nifedipine | 123 | 312 | 47 | $4,891 |
| Doxazosin Mesylate Generic | 116 | 290 | 45 | $2,071 |
| Atorvastatin Calcium Generic | 85 | 195 | 27 | $583 |
| Carvedilol Generic | 84 | 154 | 28 | $470 |
| Farxiga Dapagliflozin Propanediol | 80 | 92 | 20 | $48K |
| Veltassa Patiromer Calcium Sorbitex | 77 | 92 | 23 | $69K |
| Lisinopril Generic | 71 | 173 | 27 | $317 |
| Torsemide Generic | 65 | 121 | 14 | $613 |
| Kerendia Finerenone | 60 | 62 | Under 11 | $39K |
Brand drugs: 667 claims; generic drugs: 2,534 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tariq Mubin $704 ($704 in general payments such as food, travel and fees) from 14 companies. The largest payer was Ardelyx, Inc. with $278.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 11 | $278 |
| Fresenius USA Marketing, Inc. | 5 | $75.75 |
| Akebia Therapeutics Inc AKBA | 2 | $65.68 |
| Amgen Inc. AMGN | 2 | $42.75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39.28 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $28.64 |
| Abiomed JNJ | 1 | $28.33 |
| OPKO Pharmaceuticals, LLC | 1 | $25.2 |
| Kyowa Kirin, Inc. 4151.T | 1 | $24.38 |
| Vifor Pharma, Inc. | 1 | $21.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.